{
  "resourceType": "Questionnaire",
  "extension": [
      {
          "url": "http://hl7.org/fhir/StructureDefinition/cqf-library",
          "valueCanonical": "<FHIR-server>/Library/library-botulinumtoxin-BotulinumToxin"
      }
  ],
  "url": "<FHIR-server>/Questionnaire/questionnaire-botulinumtoxin-BotulinumToxin",
  "identifier": [
      {
          "system": "http://identifiers.mettles.com/prior_authorization",
          "value": "medicare_fee_for_service-botulinum_toxin"
      }
  ],
  "name": "BotulinumToxin",
  "version": "1.0.0",
  "title": "Prior Authorization for Botulinum Toxin",
  "status": "draft",
  "subjectType": [
      "Patient"
  ],
  "date": "2024-12-24",
  "publisher": "CMS",
  "item": [
      {
          "linkId": "10",
          "text": "Botulinum Toxin Injection Contraindication",
          "type": "group",
          "item": [
              {
                  "linkId": "10.1",
                  "text": "Does the beneficiary have a condition that is a contraindication to receiving botulinum toxin?",
                  "type": "boolean"
              },
              {
                  "linkId": "10.2",
                  "text": "Does the beneficiary have existing medical condition(s) which could affect the neuromuscular function?",
                  "type": "boolean"
              },
              {
                  "linkId": "10.3",
                  "text": "Does the beneficiary have a hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation of the serotype?",
                  "type": "boolean"
              },
              {
                  "linkId": "10.4",
                  "text": "Does the beneficiary have a severe clotting disorder?",
                  "type": "boolean"
              },
              {
                  "linkId": "10.5",
                  "text": "Does the beneficiary have an infection at the proposed injection site?",
                  "type": "boolean"
              },
              {
                  "linkId": "10.6",
                  "text": "Provider education note; any of the above contraindications will indicate botulinum toxin is not reasonable nor necessary.​",
                  "type": "display"
              }
          ]
      },
      {
          "linkId": "1",
          "text": "Order Details",
          "type": "group",
          "item": [
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "OrderDate"
                          }
                      }
                  ],
                  "linkId": "1.1",
                  "text": "Order date",
                  "type": "date",
                  "required": true
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "RequestedDate"
                          }
                      }
                  ],
                  "linkId": "1.2",
                  "text": "Requested procedure date of service",
                  "type": "date",
                  "required": true
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "RequestedInjectionOccurence"
                          }
                      }
                  ],
                  "linkId": "1.3",
                  "text": "The requested procedure is one of the following",
                  "type": "choice",
                  "required": true,
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "Initial injection",
                              "display": "Initial injection"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Subsequent injection",
                              "display": "Subsequent injection"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Last injection",
                              "display": "Last injection"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "One time dose/trial dose",
                              "display": "One time dose/trial dose"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "ProposedFrequency"
                          }
                      }
                  ],
                  "linkId": "1.4",
                  "text": "Proposed frequency of injections.  Provider Note: Administration must not be given more frequently than every 12 weeks, regardless of diagnosis, unless specifically address in the policy.",
                  "type": "text",
                  "required": true
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "Orderdescription"
                          }
                      }
                  ],
                  "linkId": "1.5",
                  "text": "Order Description; A request for injection of chemical (botulinum toxin) for destruction of nerve muscles (chemodenervation).",
                  "type": "choice",
                  "required": true,
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "64612",
                              "display": "CPT 64612 - Chemodenervation of muscles(s); muscle(s) innervated by facial nerve, unilateral (e.g.m for blepharospasm, hemifacial spasm)"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "64615",
                              "display": "CPT 64615 - Chemodenervation of muscles(s); muscle(s) innervated by facial, trigeminal, cervical, spinal and accessory nerves, bilateral (e.g., for chronic migraine)"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "MedicalNecessaryReason"
                          }
                      }
                  ],
                  "linkId": "1.5.a",
                  "text": "The medically necessary reason that supports Guidance procedure code CPT 95873 or CPT 95874  (if applicable) in conjunction with chemodenervation",
                  "type": "choice",
                  "required": true,
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "N/A",
                              "display": "N/A"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "95873",
                              "display": "CPT 95873 - Muscle stimulation guidance will be used during chemodenervation to avoid the documented structures that are adjacent to or behind the target muscle, reducing the risk of complications.​"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "95874",
                              "display": "CPT 95874 - Electromyographic guidance for chemodenervation to avoid the documented structures that are adjacent to or behind the target muscle, reducing the risk of complications​"
                          }
                      }
                  ]
              }
          ]
      },
      {
          "linkId": "2",
          "text": "Covered Diagnosis",
          "type": "group",
          "item": [
              {
                  "linkId": "2.0",
                  "text": "Provider education: There must be objective documentation of the clinical features consistent with the covered diagnosis in the beneficiary record.",
                  "type": "display"
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "J0585INJECTION64612"
                          }
                      }
                  ],
                  "linkId": "2.1",
                  "text": "J0585 INJECTION, ONABOTULINUMTOXINA, 1 UNIT in conjunction with 64612 - allowable diagnosis:",
                  "type": "choice",
                  "required": true,
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "G24.4",
                              "display": "Idiopathic orofacial dystonia​"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "G24.5",
                              "display": "Blepharospasm"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "G24.8",
                              "display": "Other Dystonia"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "G51.31",
                              "display": "Clonic hemifacial spasm, right​"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "G51.32",
                              "display": "CClonic hemifacial spasm, left​"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "G51.33",
                              "display": "Clonic hemifacial spasm, bilateral​​"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Other",
                              "display": "Other"
                          }
                      }
                  ]
              },
              {
                  "linkId": "2.1.a",
                  "text": "The use of the selected serotype is not approved by the FDA and falls outside of treatment guidelines.  Submit robust published evidence for this off label request AND the reason an approved serotype is not used.",
                  "type": "text",
                  "required": true,
                  "enableWhen": [
                      {
                          "operator": "=",
                          "question": "2.1",
                          "answerCoding": {
                              "code": "Other",
                              "display": "Other"
                          }
                      }
                  ]
              },
              {
                  "linkId": "2.2",
                  "text": "Chronic Migraine (without aura) Covered Diagnosis",
                  "type": "group",
                  "item": [
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "J0585INJECTION64615WithoutAura"
                                  }
                              }
                          ],
                          "linkId": "2.2.a",
                          "text": "J0585 INJECTION, ONABOTULINUMTOXINA, 1 UNIT in conjunction with 64615 - allowable diagnosis:",
                          "type": "choice",
                          "required": true,
                          "answerOption": [
                              {
                                  "valueCoding": {
                                      "code": "G43.001",
                                      "display": "Migraine without aura, not intractable, with status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.009",
                                      "display": "Migraine without aura, not intractable, without status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.011",
                                      "display": "Migraine without aura, intractable, with status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.019",
                                      "display": "Migraine without aura, intractable, without status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.101",
                                      "display": "Migraine with aura, not intractable, with status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.109",
                                      "display": "Migraine with aura, not intractable, without status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.111",
                                      "display": "Migraine with aura, intractable, with status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.119",
                                      "display": "Migraine with aura, intractable, without status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.401",
                                      "display": "Hemiplegic migraine, not intractable, with status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.409",
                                      "display": "Hemiplegic migraine, not intractable, without status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.411",
                                      "display": "Hemiplegic migraine, intractable, with status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.419",
                                      "display": "Hemiplegic migraine, intractable, without status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.501",
                                      "display": "Persistent migraine aura without cerebral infarction, not intractable, with status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.509",
                                      "display": "Persistent migraine aura without cerebral infarction, not intractable, without status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.511",
                                      "display": "Persistent migraine aura without cerebral infarction, intractable, with status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.519",
                                      "display": "Persistent migraine aura without cerebral infarction, intractable, without status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.601",
                                      "display": "Persistent migraine aura with cerebral infarction, not intractable, with status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.609",
                                      "display": "Persistent migraine aura with cerebral infarction, not intractable, without status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.611",
                                      "display": "Persistent migraine aura with cerebral infarction, intractable, with status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.619",
                                      "display": "Persistent migraine aura with cerebral infarction, intractable, without status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.701",
                                      "display": "Chronic migraine without aura, not intractable, with status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.709",
                                      "display": "Chronic migraine without aura, not intractable, without status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.711",
                                      "display": "Chronic migraine without aura, intractable, with status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.719",
                                      "display": "Chronic migraine without aura, intractable, without status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.A0",
                                      "display": "Cyclical vomiting, in migraine, not intractable"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.A1",
                                      "display": "Cyclical vomiting, in migraine, intractable"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.B0",
                                      "display": "Ophthalmoplegic migraine, not intractable"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.B1",
                                      "display": "Ophthalmoplegic migraine, intractable"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.C0",
                                      "display": "Periodic headache syndromes in child or adult, not intractable"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.C1",
                                      "display": "Periodic headache syndromes in child or adult, intractable"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.D0",
                                      "display": "Abdominal migraine, not intractable"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.D1",
                                      "display": "Abdominal migraine, intractable"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.801",
                                      "display": "Other migraine, not intractable, with status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.809",
                                      "display": "Other migraine, not intractable, without status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.811",
                                      "display": "Other migraine, intractable, with status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.819",
                                      "display": "Other migraine, intractable, without status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "Other",
                                      "display": "Other"
                                  }
                              }
                          ]
                      },
                      {
                          "linkId": "2.2.b",
                          "text": "The use of the selected serotype is not approved by the FDA and falls outside of treatment guidelines.  Submit robust published evidence for this off label request AND the reason an approved serotype is not used.​",
                          "type": "text",
                          "required": true,
                          "enableWhen": [
                              {
                                  "operator": "=",
                                  "question": "2.2.a",
                                  "answerCoding": {
                                      "code": "Other",
                                      "display": "Other"
                                  }
                              }
                          ]
                      }
                  ]
              },
              {
                  "linkId": "2.3",
                  "text": "Chronic Migraine (with aura) Covered Diagnosis",
                  "type": "group",
                  "item": [
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "J0585INJECTION64615WithAura"
                                  }
                              }
                          ],
                          "linkId": "2.3.a",
                          "text": "J0585 INJECTION, ONABOTULINUMTOXINA, 1 UNIT in conjunction with 64615 - allowable diagnosis:",
                          "type": "choice",
                          "required": true,
                          "answerOption": [
                              {
                                  "valueCoding": {
                                      "code": "G43.901",
                                      "display": "Migraine, unspecified, not intractable, with status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.909",
                                      "display": "Migraine, unspecified, not intractable, without status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.911",
                                      "display": "Migraine, unspecified, intractable, with status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.919",
                                      "display": "Migraine, unspecified, intractable, without status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.E01",
                                      "display": "Chronic migraine with aura, not intractable, with status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.E09",
                                      "display": "Chronic migraine with aura, not intractable, without status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.E11",
                                      "display": "Chronic migraine with aura, intractable, with status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "G43.E19",
                                      "display": "Chronic migraine with aura, intractable, without status migrainosus"
                                  }
                              },
                              {
                                  "valueCoding": {
                                      "code": "Other",
                                      "display": "Other"
                                  }
                              }
                          ]
                      },
                      {
                          "linkId": "2.3.b",
                          "text": "The use of the selected serotype is not approved by the FDA and falls outside of treatment guidelines.  Submit robust published evidence for this off label request AND the reason an approved serotype is not used.​",
                          "type": "text",
                          "required": true,
                          "enableWhen": [
                              {
                                  "operator": "=",
                                  "question": "2.3.a",
                                  "answerCoding": {
                                      "code": "Other",
                                      "display": "Other"
                                  }
                              }
                          ]
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "J0586INJECTION64612"
                          }
                      }
                  ],
                  "linkId": "2.4",
                  "text": "J0586 INJECTION, ABOBOTULINUMTOXINA, 5 UNITS in conjunction with 64612 - allowable diagnosis:",
                  "type": "choice",
                  "required": true,
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "G24.4",
                              "display": "Idiopathic orofacial dystonia"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "G24.5",
                              "display": "Blepharospasm"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "G24.8",
                              "display": "Other Dystonia"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "G51.31",
                              "display": "Clonic hemifacial spasm, right"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "G51.32",
                              "display": "Clonic hemifacial spasm, left"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "G51.33",
                              "display": "Clonic hemifacial spasm, bilateral"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Other",
                              "display": "Other"
                          }
                      }
                  ]
              },
              {
                  "linkId": "2.4.a",
                  "text": "The use of the selected serotype is not approved by the FDA and falls outside of treatment guidelines.  Submit robust published evidence for this off label request AND the reason an approved serotype is not used.",
                  "type": "text",
                  "required": true,
                  "enableWhen": [
                      {
                          "operator": "=",
                          "question": "2.4",
                          "answerCoding": {
                              "code": "Other",
                              "display": "Other"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "J0588INJECTION64612"
                          }
                      }
                  ],
                  "linkId": "2.5",
                  "text": "J0588 INJECTION, INCOBOTULINUMTOXIN A, 1 UNIT in conjunction with 64612 allowable diagnosis",
                  "type": "choice",
                  "required": true,
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "G24.5",
                              "display": "Blepharospasm"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Other",
                              "display": "Other"
                          }
                      }
                  ]
              },
              {
                  "linkId": "2.5.a",
                  "text": "The use of the selected serotype is not approved by the FDA and falls outside of treatment guidelines.  Submit robust published evidence for this off label request AND the reason an approved serotype is not used.",
                  "type": "text",
                  "required": true,
                  "enableWhen": [
                      {
                          "operator": "=",
                          "question": "2.5",
                          "answerCoding": {
                              "code": "Other",
                              "display": "Other"
                          }
                      }
                  ]
              }
          ]
      },
      {
          "linkId": "3",
          "text": "Botulinum toxin, strength, and total dosage requested",
          "type": "group",
          "item": [
              {
                  "linkId": "3.1",
                  "text": "J0585 Injection, onabotulinumtoxinA(Botox), 1 unit",
                  "type": "group",
                  "item": [
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "J0585INJECTION50Units"
                                  }
                              }
                          ],
                          "linkId": "3.1.1",
                          "text": "50 units per vial, vacuum-dried powder for reconstitution",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "J0585INJECTION100Units"
                                  }
                              }
                          ],
                          "linkId": "3.1.2",
                          "text": "100 units per vial, vacuum-dried powder for reconstitution",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "J0585INJECTION200Units"
                                  }
                              }
                          ],
                          "linkId": "3.1.3",
                          "text": "200 units per vial, vacuum-dried powder for reconstitution",
                          "type": "number"
                      }
                  ]
              },
              {
                  "linkId": "3.2",
                  "text": "J0586 - Injection abobotulinumtoxinA (Dysport), 5 units",
                  "type": "group",
                  "item": [
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "J0586INJECTION300Units"
                                  }
                              }
                          ],
                          "linkId": "3.2.1",
                          "text": "300 units per vial, vacuum-dried powder for reconstitution",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "J0586INJECTION500Units"
                                  }
                              }
                          ],
                          "linkId": "3.2.2",
                          "text": "500 units per vial, vacuum-dried powder for reconstitution",
                          "type": "number"
                      }
                  ]
              },
              {
                  "linkId": "3.3",
                  "text": "J0587- Injection rimabotulinumtoxinB (Myobloc), 100 units",
                  "type": "group",
                  "item": [
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "J0587INJECTION2500Units"
                                  }
                              }
                          ],
                          "linkId": "3.3.1",
                          "text": "2500 units per vial, vacuum-dried powder for reconstitution",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "J0587INJECTION5000Units"
                                  }
                              }
                          ],
                          "linkId": "3.3.2",
                          "text": "5000 units per vial, vacuum-dried powder for reconstitution",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "J0587INJECTION10000Units"
                                  }
                              }
                          ],
                          "linkId": "3.3.3",
                          "text": "10000 units per vial, vacuum-dried powder for reconstitution",
                          "type": "number"
                      }
                  ]
              },
              {
                  "linkId": "3.4",
                  "text": "J0588- Injection incobotulinumtoxinA (Xeomin), 1 unit",
                  "type": "group",
                  "item": [
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "J0588INJECTION50Units"
                                  }
                              }
                          ],
                          "linkId": "3.4.1",
                          "text": "50 units per vial, vacuum-dried powder for reconstitution",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "J0588INJECTION100Units"
                                  }
                              }
                          ],
                          "linkId": "3.4.2",
                          "text": "100 units per vial, vacuum-dried powder for reconstitution",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "J0588INJECTION200Units"
                                  }
                              }
                          ],
                          "linkId": "3.4.3",
                          "text": "200 units per vial, vacuum-dried powder for reconstitution",
                          "type": "number"
                      }
                  ]
              }
          ]
      },
      {
          "linkId": "4",
          "text": "Complete anatomic description of the site(s) to be injected and dosage for each injection site",
          "type": "group",
          "item": [
              {
                  "linkId": "4.1",
                  "text": "Blepharospasm  FDA approved for Botox (BOTOX)",
                  "type": "group",
                  "item": [
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "BlepharospasmBotoxMedialUpperLid"
                                  }
                              }
                          ],
                          "linkId": "4.1.1",
                          "text": "Medial pre-tarsal orbicularis oculi muscle of the upper lid",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "BlepharospasmBotoxLateralUpperLid"
                                  }
                              }
                          ],
                          "linkId": "4.1.2",
                          "text": "Lateral pre-tarsal orbicularis oculi muscle of the upper lid",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "BlepharospasmBotoxLateralLowerLid"
                                  }
                              }
                          ],
                          "linkId": "4.1.3",
                          "text": "Lateral pre-tarsal orbicularis oculi muscle of the lower lid",
                          "type": "number"
                      }
                  ]
              },
              {
                  "linkId": "4.2",
                  "text": "Blepharospasm FDA approved for (Xeomin)",
                  "type": "group",
                  "item": [
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "BlepharospasmXeominLateralSuperiorPreTarsal"
                                  }
                              }
                          ],
                          "linkId": "4.2.1",
                          "text": "Lateral superior pre-tarsal part of the orbicularis oculi muscle",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "BlepharospasmXeominMedialSuperiorPreTarsal"
                                  }
                              }
                          ],
                          "linkId": "4.2.2",
                          "text": "Medial superior pre-tarsal part of the orbicularis oculi muscle",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "BlepharospasmXeominLateralCanthus"
                                  }
                              }
                          ],
                          "linkId": "4.2.3",
                          "text": "Lateral canthus of the orbicularis oculi muscle",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "BlepharospasmXeominInferolateralOrbicularisOculi"
                                  }
                              }
                          ],
                          "linkId": "4.2.4",
                          "text": "Inferolateral portion of the orbicularis oculi muscle",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "BlepharospasmXeominCorrugator"
                                  }
                              }
                          ],
                          "linkId": "4.2.5",
                          "text": "Corrugator muscle",
                          "type": "number"
                      }
                  ]
              },
              {
                  "linkId": "4.3",
                  "text": "Chronic migraines FDA approved for (BOTOX)",
                  "type": "group",
                  "item": [
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "ChronicMigrainesBotoxCorrugator"
                                  }
                              }
                          ],
                          "linkId": "4.3.1",
                          "text": "Corrugator",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "ChronicMigrainesBotoxProcerus"
                                  }
                              }
                          ],
                          "linkId": "4.3.2",
                          "text": "Procerus",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "ChronicMigrainesBotoxFrontalis"
                                  }
                              }
                          ],
                          "linkId": "4.3.3",
                          "text": "Frontalis",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "ChronicMigrainesBotoxTemporalis"
                                  }
                              }
                          ],
                          "linkId": "4.3.4",
                          "text": "Temporalis",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "ChronicMigrainesBotoxOccipitalis"
                                  }
                              }
                          ],
                          "linkId": "4.3.5",
                          "text": "Occipitalis",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "ChronicMigrainesBotoxCervicalParaspinals"
                                  }
                              }
                          ],
                          "linkId": "4.3.6",
                          "text": "Cervical paraspinals",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "ChronicMigrainesBotoxTrapezius"
                                  }
                              }
                          ],
                          "linkId": "4.3.7",
                          "text": "Trapezius",
                          "type": "number"
                      }
                  ]
              },
              {
                  "linkId": "4.4",
                  "text": "Facial Hemispasm",
                  "type": "group",
                  "item": [
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "FacialHemispasmOrbicularisOculiUpperLid"
                                  }
                              }
                          ],
                          "linkId": "4.4.1",
                          "text": "Orbicularis oculi muscle of the upper lid",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "FacialHemispasmOrbicularisOris"
                                  }
                              }
                          ],
                          "linkId": "4.4.2",
                          "text": "Orbicularis oris muscles",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "FacialHemispasmZygomaticusMajor"
                                  }
                              }
                          ],
                          "linkId": "4.4.3",
                          "text": "Zygomaticus major",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "FacialHemispasmZygomaticusMinor"
                                  }
                              }
                          ],
                          "linkId": "4.4.4",
                          "text": "Zygomaticus minor",
                          "type": "number"
                      },
                      {
                          "extension": [
                              {
                                  "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                                  "valueExpression": {
                                      "language": "text/cql",
                                      "expression": "FacialHemispasmDepressorAnguliOris"
                                  }
                              }
                          ],
                          "linkId": "4.4.5",
                          "text": "Depressor anguli oris muscle",
                          "type": "number"
                      }
                  ]
              }
          ]
      },
      {
          "linkId": "4.5",
          "text": "Medical Necessity Documentation",
          "type": "group",
          "item": [
              {
                  "linkId": "4.5.1",
                  "text": "Provider Education Note:  Specific information must be documented about the conservative methods of treatments such as medication, physical therapy, and other appropriate methods that have been tried and proven unsuccessful.  The documentation must include an objective assessment of the intolerance or inadequacy of the response(s). (Excludes hemifacial spasm or blepharospasm)​",
                  "type": "text"
              }
          ]
      },
      {
          "linkId": "5",
          "text": "Unsuccessful or inadequate response to treatments (Excludes hemifacial spasm or blepharospasm)​",
          "type": "group",
          "item": [
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "MedicationsAttempted"
                          }
                      }
                  ],
                  "linkId": "5.2",
                  "text": "Medication(s) that have been attempted.",
                  "type": "choice",
                  "repeats": true,
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "Anticholinergics",
                              "display": "Anticholinergics (Muscarinic receptor antagonist)"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Benzodiazepine",
                              "display": "Benzodiazepine"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Skeletal Muscle Relaxants",
                              "display": "Skeletal Muscle Relaxants"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Other",
                              "display": "Other"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "Anticholinergics"
                          }
                      }
                  ],
                  "linkId": "5.2.1",
                  "text": "Anticholinergics (Muscarinic receptor antagonist)",
                  "type": "choice",
                  "repeats": true,
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "Benztropine",
                              "display": "Benztropine"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Trihexyphenidyl",
                              "display": "Trihexyphenidyl"
                          }
                      }
                  ],
                  "enableWhen": [
                      {
                          "operator": "=",
                          "question": "5.2",
                          "answerCoding": {
                              "code": "Anticholinergics",
                              "display": "Anticholinergics (Muscarinic receptor antagonist)"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "Benzodiazepine"
                          }
                      }
                  ],
                  "linkId": "5.2.2",
                  "text": "Benzodiazepine",
                  "type": "choice",
                  "repeats": true,
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "Clonazepam",
                              "display": "Clonazepam"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Diazepam",
                              "display": "Diazepam"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Lorazepam",
                              "display": "Lorazepam"
                          }
                      }
                  ],
                  "enableWhen": [
                      {
                          "operator": "=",
                          "question": "5.2",
                          "answerCoding": {
                              "code": "Benzodiazepine",
                              "display": "Benzodiazepine"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "SkeletalMuscleRelaxants"
                          }
                      }
                  ],
                  "linkId": "5.2.3",
                  "text": "Skeletal Muscle Relaxants",
                  "type": "choice",
                  "repeats": true,
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "Baclofen",
                              "display": "Baclofen"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Tizanidine",
                              "display": "Tizanidine"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Cyclobenzaprine",
                              "display": "Cyclobenzaprine"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Methocarbamol",
                              "display": "Methocarbamol"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Dantrolene",
                              "display": "Dantrolene"
                          }
                      }
                  ],
                  "enableWhen": [
                      {
                          "operator": "=",
                          "question": "5.2",
                          "answerCoding": {
                              "code": "Skeletal Muscle Relaxants",
                              "display": "Skeletal Muscle Relaxants"
                          }
                      }
                  ]
              },
              {
                  "linkId": "5.2.4",
                  "text": "Specify Other:",
                  "type": "text",
                  "required": true,
                  "enableWhen": [
                      {
                          "operator": "=",
                          "question": "5.2",
                          "answerCoding": {
                              "code": "Other",
                              "display": "Other"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "Conventionaltreatments"
                          }
                      }
                  ],
                  "linkId": "5.3",
                  "text": "Conventional treatment methods that have been attempted.",
                  "type": "choice",
                  "repeats": true,
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "Physical Therapy",
                              "display": "Physical Therapy"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Biobehavioral therapy​",
                              "display": "Biobehavioral therapy​"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Acupuncture",
                              "display": "Acupuncture"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Lifestyle modifications",
                              "display": "Lifestyle modifications"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "benificiarystherapeuticResponse"
                          }
                      }
                  ],
                  "linkId": "5.4",
                  "text": "Beneficiary's therapeutic response to treatments attempted",
                  "type": "choice",
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "Poor/minimal",
                              "display": "Poor/minimal"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Fair response",
                              "display": "Fair response"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Good response",
                              "display": "Good response"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Excellent",
                              "display": "Excellent"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Complete",
                              "display": "Complete"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "PertinentProcedureResults"
                          }
                      }
                  ],
                  "linkId": "5.5",
                  "text": "Pertinent test/procedure results",
                  "type": "text"
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "MedicationsAttemped2MonthTrial"
                          }
                      }
                  ],
                  "linkId": "5.1",
                  "text": "Medication(s) that have been attempted for chronic migraines with at least a 2-month trial.​ Provider Education Note: The beneficiary has had a trial of and inadequate response to a 2-month trial of at least one agent in any two of the following classes or has contraindication to the following medications.",
                  "type": "choice",
                  "repeats": true,
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "Tricyclic Antidepressants",
                              "display": "Tricyclic Antidepressants"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Beta Blocker",
                              "display": "Beta Blocker"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Calcium Channel Blocker",
                              "display": "Calcium Channel Blocker"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Antiepileptic",
                              "display": "Antiepileptic"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Other",
                              "display": "Other"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "TricyclicAntidepressants"
                          }
                      }
                  ],
                  "linkId": "5.1.1",
                  "text": "Tricyclic Antidepressants",
                  "type": "choice",
                  "repeats": true,
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "Amitriptyline",
                              "display": "Amitriptyline"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Nortriptyline",
                              "display": "Nortriptyline"
                          }
                      }
                  ],
                  "enableWhen": [
                      {
                          "operator": "=",
                          "question": "5.1",
                          "answerCoding": {
                              "code": "Tricyclic Antidepressants",
                              "display": "Tricyclic Antidepressants"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "BetaBlocker"
                          }
                      }
                  ],
                  "linkId": "5.1.2",
                  "text": "Beta Blocker",
                  "type": "choice",
                  "repeats": true,
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "Propranolol",
                              "display": "Propranolol"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Metoprolol",
                              "display": "Metoprolol"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Atenolol",
                              "display": "Atenolol"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Nadolol",
                              "display": "Nadolol"
                          }
                      }
                  ],
                  "enableWhen": [
                      {
                          "operator": "=",
                          "question": "5.1",
                          "answerCoding": {
                              "code": "Beta Blocker",
                              "display": "Beta Blocker"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "CalciumChannelBlocker"
                          }
                      }
                  ],
                  "linkId": "5.1.3",
                  "text": "Calcium Channel Blocker",
                  "type": "choice",
                  "repeats": true,
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "Verapamil",
                              "display": "Verapamil"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Nifedipine",
                              "display": "Nifedipine"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Nimodipine",
                              "display": "Nimodipine"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Nicardipine",
                              "display": "Nicardipine"
                          }
                      }
                  ],
                  "enableWhen": [
                      {
                          "operator": "=",
                          "question": "5.1",
                          "answerCoding": {
                              "code": "Calcium Channel Blocker",
                              "display": "Calcium Channel Blocker"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "Antiepileptic"
                          }
                      }
                  ],
                  "linkId": "5.1.4",
                  "text": "Antiepileptic",
                  "type": "choice",
                  "repeats": true,
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "Valproate sodium​",
                              "display": "Valproate sodium​"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Divalproex sodium​",
                              "display": "Divalproex sodium​"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Topiramate",
                              "display": "Topiramate"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Gabapentin",
                              "display": "Gabapentin"
                          }
                      }
                  ],
                  "enableWhen": [
                      {
                          "operator": "=",
                          "question": "5.1",
                          "answerCoding": {
                              "code": "Antiepileptic",
                              "display": "Antiepileptic"
                          }
                      }
                  ]
              },
              {
                  "linkId": "5.1.5",
                  "text": "Specify Other:",
                  "type": "text",
                  "required": true,
                  "enableWhen": [
                      {
                          "operator": "=",
                          "question": "5.1",
                          "answerCoding": {
                              "code": "Other",
                              "display": "Other"
                          }
                      }
                  ]
              }
          ]
      },
      {
          "linkId": "6.a",
          "text": "History of Chronic Migraines Documentation​",
          "type": "group",
          "item": [
              {
                  "linkId": "6.a.1",
                  "text": "Documented features of migraine headache ≥ 8 migraine headache days per month​",
                  "type": "text"
              },
              {
                  "linkId": "6.a.2",
                  "text": "Migraine headache documented to be lasting for a duration ≥4 hours on a migraine day​",
                  "type": "text"
              },
              {
                  "linkId": "6.a.3",
                  "text": "Supports monthly headache days have occurred ≥15 headaches days per month​",
                  "type": "text"
              },
              {
                  "linkId": "6.a.4",
                  "text": "Chronic headaches have been present for a period of at least 3 months​",
                  "type": "text"
              }
          ]
      },
      {
          "linkId": "6",
          "text": "Unsuccessful or inadequate response to treatments specific to Migraines​​",
          "type": "group",
          "item": [
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "MedicationsAttemped2MonthTrial"
                          }
                      }
                  ],
                  "linkId": "6.1",
                  "text": "Medication(s) that have been attempted for chronic migraines with at least a 2-month trial.​ Provider Education Note: The beneficiary has had a trial of and inadequate response to a 2-month trial of at least one agent in any two of the following classes or has contraindication to the following medications.",
                  "type": "choice",
                  "repeats": true,
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "Tricyclic Antidepressants",
                              "display": "Tricyclic Antidepressants"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Beta Blocker",
                              "display": "Beta Blocker"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Calcium Channel Blocker",
                              "display": "Calcium Channel Blocker"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Antiepileptic",
                              "display": "Antiepileptic"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Other",
                              "display": "Other"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "TricyclicAntidepressants"
                          }
                      }
                  ],
                  "linkId": "6.1.1",
                  "text": "Tricyclic Antidepressants",
                  "type": "choice",
                  "repeats": true,
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "Amitriptyline",
                              "display": "Amitriptyline"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Nortriptyline",
                              "display": "Nortriptyline"
                          }
                      }
                  ],
                  "enableWhen": [
                      {
                          "operator": "=",
                          "question": "6.1",
                          "answerCoding": {
                              "code": "Tricyclic Antidepressants",
                              "display": "Tricyclic Antidepressants"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "BetaBlocker"
                          }
                      }
                  ],
                  "linkId": "6.1.2",
                  "text": "Beta Blocker",
                  "type": "choice",
                  "repeats": true,
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "Propranolol",
                              "display": "Propranolol"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Metoprolol",
                              "display": "Metoprolol"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Atenolol",
                              "display": "Atenolol"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Nadolol",
                              "display": "Nadolol"
                          }
                      }
                  ],
                  "enableWhen": [
                      {
                          "operator": "=",
                          "question": "6.1",
                          "answerCoding": {
                              "code": "Beta Blocker",
                              "display": "Beta Blocker"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "CalciumChannelBlocker"
                          }
                      }
                  ],
                  "linkId": "6.1.3",
                  "text": "Calcium Channel Blocker",
                  "type": "choice",
                  "repeats": true,
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "Verapamil",
                              "display": "Verapamil"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Nifedipine",
                              "display": "Nifedipine"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Nimodipine",
                              "display": "Nimodipine"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Nicardipine",
                              "display": "Nicardipine"
                          }
                      }
                  ],
                  "enableWhen": [
                      {
                          "operator": "=",
                          "question": "6.1",
                          "answerCoding": {
                              "code": "Calcium Channel Blocker",
                              "display": "Calcium Channel Blocker"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "Antiepileptic"
                          }
                      }
                  ],
                  "linkId": "6.1.4",
                  "text": "Antiepileptic",
                  "type": "choice",
                  "repeats": true,
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "Valproate sodium​",
                              "display": "Valproate sodium​"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Divalproex sodium​",
                              "display": "Divalproex sodium​"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Topiramate",
                              "display": "Topiramate"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Gabapentin",
                              "display": "Gabapentin"
                          }
                      }
                  ],
                  "enableWhen": [
                      {
                          "operator": "=",
                          "question": "6.1",
                          "answerCoding": {
                              "code": "Antiepileptic",
                              "display": "Antiepileptic"
                          }
                      }
                  ]
              },
              {
                  "linkId": "6.1.5",
                  "text": "Specify Other:",
                  "type": "text",
                  "required": true,
                  "enableWhen": [
                      {
                          "operator": "=",
                          "question": "6.1",
                          "answerCoding": {
                              "code": "Other",
                              "display": "Other"
                          }
                      }
                  ]
              },
              {
                  "linkId": "6.1.6",
                  "text": "Calcitonin gene-related peptide agent for chronic migraine prophylaxis is currently used.​",
                  "type": "choice",
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "N/A",
                              "display": "N/A"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Yes, and the beneficiary has had a reduction in the overall number of migraine days but still has chronic migraines requiring additional therapy for chronic migraine prevention.​",
                              "display": "Yes, and the beneficiary has had a reduction in the overall number of migraine days but still has chronic migraines requiring additional therapy for chronic migraine prevention.​"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Yes, and the beneficiary has had a reduction in number of severe migraine days per month with CGRP use, but still has chronic migraines requiring additional therapy for chronic migraine prevention.​",
                              "display": "Yes, and the beneficiary has had a reduction in number of severe migraine days per month with CGRP use, but still has chronic migraines requiring additional therapy for chronic migraine prevention.​"
                          }
                      }
                  ]
              }
          ]
      },
      {
          "linkId": "7",
          "text": "Objective scale(s) to measure severity of migraine pain​",
          "type": "group",
          "item": [
              {
                  "linkId": "7.a",
                  "text": "Baseline Date:",
                  "type": "date"
              },
              {
                  "linkId": "7.0",
                  "text": "Objective scale score of the severity of pain, for Chronic Migraines e.g. Numerical Pain Scale, Verbal Descriptor.​",
                  "type": "choice",
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "0 - None",
                              "display": "0 - None"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "1 - Mild symptom(s)",
                              "display": "1 - Mild symptom(s)"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "2 - Moderate symptom(s)",
                              "display": "2 - Moderate symptom(s)"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "3 - Severe symptom(s)",
                              "display": "3 - Severe symptom(s)"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "4 - Not possible due to the disease",
                              "display": "4 - Not possible due to the disease"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Not applicable",
                              "display": "Not applicable"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "ClinicalInjectionEffectiveness"
                          }
                      }
                  ],
                  "linkId": "7.1",
                  "text": "Clinical effectiveness of the injections",
                  "type": "choice",
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "0 - Complete effectiveness",
                              "display": "0 - Complete effectiveness"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "1 - Highly effective",
                              "display": "1 - Highly effective"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "2 - Moderately effective",
                              "display": "2 - Moderately effective"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "3 - Minimally effective",
                              "display": "3 - Minimally effective"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "4 - Not effective",
                              "display": "4 - Not effective"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Not applicable",
                              "display": "Not applicable"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "benificiarysInjectionResponse"
                          }
                      }
                  ],
                  "linkId": "7.2",
                  "text": "Beneficiary’s response to the injections",
                  "type": "choice",
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "0 - Complete improvement",
                              "display": "0 - Complete improvement"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "1 - Significant improvement",
                              "display": "1 - Significant improvement"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "2 - Moderate improvement",
                              "display": "2 - Moderate improvement"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "3 - Minimal improvement",
                              "display": "3 - Minimal improvement"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "4 - No improvement",
                              "display": "4 - No improvement"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Not applicable",
                              "display": "Not applicable"
                          }
                      }
                  ]
              }
          ]
      },
      {
          "linkId": "8",
          "text": "Objective Scales -Blepharospasm​​",
          "type": "group",
          "item": [
              {
                  "linkId": "8.a",
                  "text": "Baseline Date:",
                  "type": "date"
              },
              {
                  "linkId": "8.0",
                  "text": "Objective scale score of the severity of symptoms, Moderate to severe chronic blepharospasm measured on objective clinical scale e.g. Jankovic Rating Scale (JRS) and Blepharospasm Disability Index (BSDI)​​",
                  "type": "choice",
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "0 - None",
                              "display": "0 - None"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "1 - Mild symptom(s)",
                              "display": "1 - Mild symptom(s)"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "2 - Moderate symptom(s)",
                              "display": "2 - Moderate symptom(s)"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "3 - Severe symptom(s)",
                              "display": "3 - Severe symptom(s)"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "4 - Not possible due to the disease",
                              "display": "4 - Not possible due to the disease"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Not applicable",
                              "display": "Not applicable"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "ClinicalInjectionEffectiveness"
                          }
                      }
                  ],
                  "linkId": "8.1",
                  "text": "Clinical effectiveness of the injections",
                  "type": "choice",
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "0 - Complete effectiveness",
                              "display": "0 - Complete effectiveness"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "1 - Highly effective",
                              "display": "1 - Highly effective"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "2 - Moderately effective",
                              "display": "2 - Moderately effective"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "3 - Minimally effective",
                              "display": "3 - Minimally effective"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "4 - Not effective",
                              "display": "4 - Not effective"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Not applicable",
                              "display": "Not applicable"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "benificiarysInjectionResponse"
                          }
                      }
                  ],
                  "linkId": "8.2",
                  "text": "Beneficiary’s response to the injections",
                  "type": "choice",
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "0 - Complete improvement",
                              "display": "0 - Complete improvement"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "1 - Significant improvement",
                              "display": "1 - Significant improvement"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "2 - Moderate improvement",
                              "display": "2 - Moderate improvement"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "3 - Minimal improvement",
                              "display": "3 - Minimal improvement"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "4 - No improvement",
                              "display": "4 - No improvement"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Not applicable",
                              "display": "Not applicable"
                          }
                      }
                  ]
              }
          ]
      },
      {
          "linkId": "9",
          "text": "Objective Scales (Dependent on Diagnosis)​",
          "type": "group",
          "item": [
              {
                  "linkId": "9.a",
                  "text": "Baseline Date:",
                  "type": "date"
              },
              {
                  "linkId": "9.0",
                  "text": "Objective scale score of the severity of symptoms, Moderate to severe chronic blepharospasm associated with orofacial dystonia should be measured on objective clinical scale e.g. Burke-Fahn-Marsden scale (BFMS), the global dystonia severity rating scale (GDRS), Craniocervical Dystonia Questionnaire, and the Jankovic Rating Scale (JRS)​",
                  "type": "choice",
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "0 - None",
                              "display": "0 - None"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "1 - Mild symptom(s)",
                              "display": "1 - Mild symptom(s)"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "2 - Moderate symptom(s)",
                              "display": "2 - Moderate symptom(s)"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "3 - Severe symptom(s)",
                              "display": "3 - Severe symptom(s)"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "4 - Not possible due to the disease",
                              "display": "4 - Not possible due to the disease"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Not applicable",
                              "display": "Not applicable"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "ClinicalInjectionEffectiveness"
                          }
                      }
                  ],
                  "linkId": "9.1",
                  "text": "Clinical effectiveness of the injections",
                  "type": "choice",
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "0 - Complete effectiveness",
                              "display": "0 - Complete effectiveness"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "1 - Highly effective",
                              "display": "1 - Highly effective"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "2 - Moderately effective",
                              "display": "2 - Moderately effective"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "3 - Minimally effective",
                              "display": "3 - Minimally effective"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "4 - Not effective",
                              "display": "4 - Not effective"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Not applicable",
                              "display": "Not applicable"
                          }
                      }
                  ]
              },
              {
                  "extension": [
                      {
                          "url": "http://hl7.org/fhir/StructureDefinition/cqf-expression",
                          "valueExpression": {
                              "language": "text/cql",
                              "expression": "benificiarysInjectionResponse"
                          }
                      }
                  ],
                  "linkId": "9.2",
                  "text": "Beneficiary’s response to the injections",
                  "type": "choice",
                  "answerOption": [
                      {
                          "valueCoding": {
                              "code": "0 - Complete improvement",
                              "display": "0 - Complete improvement"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "1 - Significant improvement",
                              "display": "1 - Significant improvement"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "2 - Moderate improvement",
                              "display": "2 - Moderate improvement"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "3 - Minimal improvement",
                              "display": "3 - Minimal improvement"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "4 - No improvement",
                              "display": "4 - No improvement"
                          }
                      },
                      {
                          "valueCoding": {
                              "code": "Not applicable",
                              "display": "Not applicable"
                          }
                      }
                  ]
              }
          ]
      }
  ]
}